FDA eases ADHD drugs heart-disease concerns
by on Apr.08, 2011, under Health and Fitness
The U.S. drugs regulator said it was not recommending changes in the use of stimulants such as Adderall XR and Ritalin to treat hyperactivity, after a review of a study into potential heart disease risks from the drugs.
View full post on Yahoo! Health News
